TheraRadar
← Back
Data updated: Mar 29, 2026

AM REGENT

CardiovascularOncologyMetabolic
Generics

AM REGENT is a generic drug manufacturer focused on Cardiovascular, Oncology, Metabolic. Key products include INJECTAFER.

1972
Since
76
Drugs
-
Trials
507
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 44%
4 drugs
Oncology 22%
2 drugs
Metabolic 11%
1 drugs
Gastroenterology 11%
1 drugs
Respiratory 11%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...